Literature DB >> 16783504

Provider choice of quality and surplus.

Nolan Miller1, Karen Eggleston, Richard Zeckhauser.   

Abstract

We study the quality choices of institutional health-care providers, such as hospitals, assuming that the utility function of the key organizational decision maker includes both quality of care and financial surplus. We are primarily concerned with how changes in outside claims--particularly proportional outside claims--on the provider's financial surplus affect his choice of quality. We use the term "rate of surplus retention" to refer to the fraction of surplus remaining after deducting all such claims. Using the Arrow-Pratt coefficient of relative risk aversion as a measure of curvature of the provider's utility-from-money function, we show that increasing the surplus retention rate increases (decreases) quality if the provider's coefficient of relative risk aversion is greater than (less than) 1.

Mesh:

Year:  2006        PMID: 16783504     DOI: 10.1007/s10754-006-7107-7

Source DB:  PubMed          Journal:  Int J Health Care Finance Econ        ISSN: 1389-6563


  4 in total

1.  Optimal payment systems for health services.

Authors:  R P Ellis; T G McGuire
Journal:  J Health Econ       Date:  1990       Impact factor: 3.883

2.  Nonprofit firms in medical markets.

Authors:  M V Pauly
Journal:  Am Econ Rev       Date:  1987-05

3.  Economics, values, and health care reform.

Authors:  V R Fuchs
Journal:  Am Econ Rev       Date:  1996-03

Review 4.  Physician response to fee changes with multiple payers.

Authors:  T G McGuire; M V Pauly
Journal:  J Health Econ       Date:  1991       Impact factor: 3.883

  4 in total
  2 in total

1.  Physician Agency and Patient Survival.

Authors:  Mireille G Jacobson; Tom Y Chang; Craig C Earle; Joseph P Newhouse
Journal:  J Econ Behav Organ       Date:  2016-12-02

2.  Does winning a pay-for-performance bonus improve subsequent quality performance? Evidence from the Hospital Quality Incentive Demonstration.

Authors:  Andrew Ryan; Matthew Sutton; Tim Doran
Journal:  Health Serv Res       Date:  2013-08-01       Impact factor: 3.402

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.